カテゴリ： Allied Market Research, 世界, 医療/バイオ

眼科用デバイスの世界市場2020–2027：製品機能別（外科用デバイス、診断装置、ビジョンケア機器）

◆英語タイトル：Ophthalmic Devices Market by Product Function [Surgical Devices (Refractive Error Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Vitreoretinal Surgery Devices) Ophthalmic Diagnostic Devices (Refractors, Corneal Topography Systems, Retinal Ultrasound Systems, Fundus Camera, Ophthalmoscopes, OCT, Perimeters, Slit Lamps, and Tonometer), and Vision Care Devices (Contact Lenses and Spectacles)]: Global Opportunity Analysis and Industry Forecast, 2020–2027
◆商品コード：AMR20PL065
◆発行会社（リサーチ会社）：Allied Market Research
◆発行日：2020年6月
◆ページ数：175
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD5,769 ⇒換算￥599,976見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算￥670,800見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算￥935,480見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、眼科用デバイスの世界市場について調査・分析することにより、イントロダクション、エグゼクティブサマリー、市場概要、製品機能別（外科用デバイス、診断装置、ビジョンケア機器）分析、地域別分析、企業情報など、今後の市場展望をまとめております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・眼科用デバイスの世界市場規模：製品機能別（外科用デバイス、診断装置、ビジョンケア機器）
・眼科用デバイスの世界市場規模：地域別
・企業情報
【レポートの概要】

The global ophthalmic devices market was valued at $32,534.0 million in 2019, and is projected to reach $44,865.0 million by 2027, registering a CAGR of 4.0 % from 2020 to 2027.

Ophthalmology is a branch of medical science that deals with the structure, function, and various eye diseases. Ophthalmic devices are medical equipment designed for diagnosis, surgery, and vision correction. These devices are gaining increased importance and adoption due to surge in prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision-related issues.

The growth of the global ophthalmic devices market is majorly driven by rise in adoption of digital devices, including laptops, smartphones, and computers, e-readers; rapid technological advancements in ophthalmic devices such as intraocular lenses (IOLs) coupled with increasing focus on customer training and education for the use of ophthalmic devices which would help in building the staff skills; and surge in awareness related to devices used in ophthalmology. However, low awareness regarding eye-related diseases and dearth of skilled professionals are expected to hamper the growth of the market. Also, emerging countries such as China, India and other Asia-Pacific countries possess high growth potential, owing to the improving healthcare infrastructures in these countries.

Based on product function, the report segments the global ophthalmic devices market into ophthalmic surgical devices, diagnostic devices, and vision care devices. The ophthalmic surgical devices segment is further categorized into refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, and vitreoretinal surgical devices. The cataract surgery devices segment dominated the ophthalmic surgical devices market in 2019, and is expected to reach $5,219.6 by 2017, registering a CAGR of 3.9% from 2020 to 2027.

The ophthalmic diagnostic devices segment is sub segmented into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometer. The retinal ultrasound segment is expected to reach $3,286.6 by 2027, registering a CAGR of 4.4% from 2020 to 2027.

The vision care devices segment is bifurcated into contact lenses and spectacle lenses. The spectacle leases segment is expected to reach $12,669 by 2027, registering a CAGR of 3.6% from 2020 to 2027.
On a regional level, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America ophthalmic devices market accounted for the largest share; however, the Asia-Pacific region is anticipated to grow with the highest CAGR of 4.5% during the forecast period.

The global ophthalmology devices market is highly competitive in nature, as major players have focused on the development and launch of innovative products to garner maximum share in the competitive market. The key players operating in the market include Abbott Laboratories, Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., and Ziemer Ophthalmic Systems AG. The other players in the industry include Sonomed Escalon, Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global ophthalmic devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global ophthalmic devices market growth.

KEY MARKET SEGMENTS
By Product Function
• Ophthalmic Surgical Devices
o Refractive Error Surgical Devices
o Glaucoma Surgical Devices
o Cataract Surgery Devices
o Vitreoretinal Surgical Devices
• Ophthalmic Diagnostic Devices
o Refractors
o Corneal Topography Systems
o Retinal Ultrasound Systems
o Fundus Camera
o Ophthalmoscopes
o Optical Coherence Tomography Systems
o Perimeters
o Slit Lamps
o Tonometer’s
• Ophthalmic Vision Care Devices
o Contact Lenses
o Spectacle Lenses

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Rest of Asia-Pacific
• LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA

List of key players profiled in the report
• Novartis AG
• Carl Zeiss Meditec AG
• Essilor International S.A.
• HAAG-Streit Holding AG
• Johnson & Johnson
• Nidek Co., Ltd.
• Topcon Corporation
• Valeant Pharmaceuticals International, Inc.
• Ziemer Ophthalmic Systems AG
• Hoya Corporation

List of other players in the value chain (profiles not included in the report):
• Sonomed Escalon
• Gulden Ophthalmics
• FCI Ophthalmics
• Glaukos Corporation
• STAAR Surgical GE Healthcare (U.K.)

【レポートの目次】

CHAPTER 1: INTRODUCTION

1.1. Report description

1.1.1. Key benefits for stakeholders
1.1.2. Key market segments

1.2. Research methodology

1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top player positioning, 2019
3.2.3. Key forces shaping the global ophthalmic devices market

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rise in prevalence of eye-related diseases worldwide
3.3.1.2. Rapid technological advancements in ophthalmic
3.3.1.3. Increase in focus on customer training and education along with awareness
3.3.1.4. High adoption of digital devices worldwide

3.3.2. Restraints

3.3.2.1. Low awareness about eye-related diseases
3.3.2.2. Dearth of skilled professionals53

3.3.3. Opportunities

3.3.3.1. Potential growth opportunities in emerging nations for ophthalmic devices manufacturers

3.4. GOVERNMENT REGULATIONS

3.4.1. FDA
3.4.2. CE Mark
3.4.3. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)

CHAPTER 4: OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION

4.1. Overview

4.1.1. Market size and forecast, by region

4.2. Surgical devices

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Refractive error surgical devices

4.2.3.1. Market size and forecast

4.2.4. Glaucoma surgical devices

4.2.4.1. Market size and forecast

4.2.5. Cataract surgical devices

4.2.5.1. Market size and forecast

4.2.6. Vitreoretinal surgical devices

4.2.6.1. Market size and forecast

4.3. Diagnostic devices

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Refractors

4.3.3.1. Market size and forecast

4.3.4. Corneal topography systems

4.3.4.1. Market size and forecast

4.3.5. Retinal ultrasound systems

4.3.5.1. Market size and forecast

4.3.6. Fundus camera

4.3.6.1. Market size and forecast

4.3.7. Ophthalmoscopes

4.3.7.1. Market size and forecast

4.3.8. Optical coherence tomography systems

4.3.8.1. Market size and forecast

4.3.9. Perimeters

4.3.9.1. Market size and forecast

4.3.10. Slit lamps

4.3.10.1. Market size and forecast

4.3.11. Tonometer

4.3.11.1. Market size and forecast

4.4. Vision care devices

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Contact lenses

4.4.3.1. Market size and forecast

4.4.4. Spectacle lenses

4.4.4.1. Market size and forecast

CHAPTER 5: OPHTHALMIC DEVICES MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast

5.2. North America

5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by product function
5.2.3. Market size and forecast, by region
5.2.4. U.S.

5.2.4.1. Market size and forecast, by product function

5.2.5. Canada

5.2.5.1. Market size and forecast, by product function

5.2.6. Mexico

5.2.6.1. Market size and forecast, by product function

5.3. Europe

5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by product function
5.3.3. Market size and forecast, by region
5.3.4. Germany

5.3.4.1. Market size and forecast, by product function

5.3.5. France

5.3.5.1. Market size and forecast, by product function

5.3.6. UK

5.3.6.1. Market size and forecast, by product function

5.3.7. Italy

5.3.7.1. Market size and forecast, by product function

5.3.8. Spain

5.3.8.1. Market size and forecast, by product function

5.3.9. Rest of the Europe

5.3.9.1. Market size and forecast, by product function

5.4. Asia-Pacific

5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by product function
5.4.3. Market size and forecast, by region
5.4.4. Japan

5.4.4.1. Market size and forecast, by product function

5.4.5. China

5.4.5.1. Market size and forecast, by product function
5.4.6. Australia market size and forecast
5.4.6.1. Market size and forecast, by product function

5.4.7. India

5.4.7.1. Market size and forecast, by product function

5.4.8. Rest of Asia-Pacific

5.4.8.1. Market size and forecast, by product function

5.5. LAMEA

5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by product function
5.5.3. Market size and forecast, by region
5.5.4. Brazil

5.5.4.1. Market size and forecast, by product function

5.5.5. Saudi Arabia market size and forecast

5.5.5.1. Market size and forecast, by product function

5.5.6. South Africa

5.5.6.1. Market size and forecast, by product function

5.5.7. Rest of LAMEA

5.5.7.1. Market size and forecast, by product function

CHAPTER 6: COMPANY PROFILES

6.1. Carl Zeiss Meditec AG

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments

6.2. Essilor International S.A.

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.2.6. Key strategic moves and developments

6.3. Haag-Streit holding Ag

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments

6.4. Hoya Corporation

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Business performance
6.4.5. Key strategic moves and developments

6.5. Johnson & Johnson

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.5.6. Key strategic moves and developments

6.6. NIDEK CO., LTD.

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Key strategic moves & developments

6.7. Novartis AG (ALCON-a division of Novartis)

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance

6.8. Topcon Corporation

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance

6.9. Bausch Health Companies Inc.

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance

6.10. Ziemer Ophthalmic Systems AG

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Product portfolio

6.11. List of mergers and acquisitions (M&A) activities

LIST OF TABLES

TABLE 01. GLOBAL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 02. OPHTHALMIC SURGICAL DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 03. OPHTHALMIC DIAGNOSTIC DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 04. OPHTHALMIC VISION CARE DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 05. OPHTHALMIC DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06. NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 07. NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 08. U.S. OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 09. CANADA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 10. MEXICO OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 11. EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 12. EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 13. GERMANY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 14. FRANCE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 15. UK OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 16. ITALY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 17. SPAIN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 18. REST OF EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 19. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 20. ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 21. JAPAN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 22. CHINA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 23. AUSTRALIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 24. INDIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 25. REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 26. LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 27. LAMEA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 28. BRAZIL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 29. SAUDI ARABIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 30. SOUTH AFRICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 31. REST OF LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 32. CARL ZEISS: COMPANY SNAPSHOT
TABLE 33. CARL ZEISS: OPERATING SEGMENTS
TABLE 34. CARL ZEISS: PRODUCT PORTFOLIO
TABLE 35. ESSILOR: COMPANY SNAPSHOT
TABLE 36. ESSILOR: OPERATING SEGMENTS
TABLE 37. ESSILOR: PRODUCT PORTFOLIO
TABLE 38. HAAG-STREIT: COMPANY SNAPSHOT
TABLE 39. HAAG-STREIT: OPERATING SEGMENTS
TABLE 40. HOYA: COMPANY SNAPSHOT
TABLE 41. HOYA: OPERATING SEGMENTS
TABLE 42. J&J: COMPANY SNAPSHOT
TABLE 43. J&J: OPERATING SEGMENTS
TABLE 44. J&J: PRODUCT PORTFOLIO
TABLE 45. NIDEK: COMPANY SNAPSHOT
TABLE 46. NIDEK: OPERATING SEGMENTS
TABLE 47. NOVARTIS: COMPANY SNAPSHOT
TABLE 48. NOVARTIS: OPERATING SEGMENTS
TABLE 49. NOVARTIS: PRODUCT PORTFOLIO
TABLE 50. TOPCON: COMPANY SNAPSHOT
TABLE 51. TOPCON: OPERATING SEGMENTS
TABLE 52. TOPCON: PRODUCT PORTFOLIO
TABLE 53. BAUSCH HEALTH COMPANIES: COMPANY SNAPSHOT
TABLE 54. BAUSCH HEALTH COMPANIES : OPERATING SEGMENTS
TABLE 55. BAUSCH HEALTH COMPANIES: PRODUCT PORTFOLIO
TABLE 56. ZEIMER: COMPANY SNAPSHOT
TABLE 57. ZIEMER: PRODUCT PORTFOLIO

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[眼科用デバイスの世界市場2020–2027：製品機能別（外科用デバイス、診断装置、ビジョンケア機器）]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 耳鼻咽喉科装置の世界市場：製品種類別（診断装置、外科用装置、補聴器、画像誘導手術システム、その他）、エンドユーザー別（病院、耳鼻咽喉科、その他）
    AMR20MY0118 / Allied Market Research / 2020年2月 / 本調査レポートでは、耳鼻咽喉科装置の世界市場について調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、製品別（診断装置、外科用装置、補聴器、画像誘導手術システム、その他）分析、エンドユーザー別（病院、耳鼻咽喉科、その他）分析、地域別分析、企業概要などを含め、今後の方向性を明らかに致します。 ・イントロダクション ・エグゼクティブサマリ－ ・市場概要 ・耳鼻咽喉科装置の世界市場：製品別（診断装置、外科用装置、補聴器、画像誘導手術システム、その他） ・耳鼻咽喉科装置の世界市場：エンドユーザー別（病院、耳鼻咽喉科、その他） ・耳鼻咽喉科装置の世界市場：地域別 ・企業概要...The global otorhinolaryngology devices market was valued at $9,268 million in 2018, and is projected to reach $13,999 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.Otorhinolaryngology devices are used to treat and diagnose disorders related to ear, nose, and throat, such as smelling disorders, hearing disorders as well as problems associated with speaking or snoring. It includes several diagnostics and surgical products such as endoscopes, powered surgical instruments, handheld surgical instruments, balloon sinus dilation devices, hearing screening devices, hearing aids, hearing implants, CO2 lasers, image-guided surgery systems, ear tubes, nasal and otological devices. These otorhinolaryngology devices...
  2. 世界の心血管デバイス市場2020-2027：製品種類別（診断及び監視デバイス、外科用デバイス）、用途別、エンドユーザー別、地域別
    BZW20PL044 / Bizwit Research & Consulting / 2020年8月7日 / 本調査レポートでは、心血管デバイスの世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、製品種類別（診断及び監視デバイス、外科用デバイス）分析、用途別分析、エンドユーザー別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。 ・エグゼクティブサマリー ・市場定義・範囲 ・市場動向 ・市場分析 ・心血管デバイスの世界市場規模：製品種類別（診断及び監視デバイス、外科用デバイス） ・心血管デバイスの世界市場規模：用途別 ・心血管デバイスの世界市場規模：エンドユーザー別 ・心血管デバイスの世界市場規模：地域別 ・競争状況...Global Cardiovascular Devices Market is valued at approximately USD 43 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2020-2027. Cardiovascular diseases (CVDs) is the major cause of mortality and morbidity all over the world. The CVDs are the diseases associated with the heart and blood vessels and include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other heart conditions. Some of the main factors that lead to the prevalence of cardiovascular disease are the consumption of tobacco, physical inactivity, and unhealthy diet, which can raise the...
  3. 心血管疾患用医療機器の世界市場予測2017-2027：検査装置、診断装置、手術装置
    VGAIN702045 / visiongain / 2016年12月 / 当調査レポートでは、心血管疾患用医療機器の世界市場について調査・分析し、心血管疾患用医療機器の世界市場規模、市場動向、市場予測、関連企業情報などを含め、以下の構成でお届けいたします。 ・レポートの概要 ・イントロダクション ・心血管疾患用医療機器の世界市場 　（市場規模予測、市場動向、市場の成長要因・阻害要因など） ・心血管疾患用医療機器の世界市場：セグメント別市場分析 ・心血管疾患用医療機器の世界市場：地域別市場分析、市場規模予測 ・市場環境分析 ・専門家の見解 ・主要企業分析...The global cardiovascular devices market was valued at $40.05bn in 2016. Visiongain estimates that this market will grow at a CAGR of 6.4% in the first half of the forecast period and reach $54.22bn in 2021.This market is estimated to grow faster in the second half of the forecast period, growing at a CAGR of 7.1% and reach $81.38bn in 2027. The global cardiovascular devices market is estimated to grow at a CAGR of 6.7% from 2017 to 2027. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this...
  4. カプノグラフィーの世界市場2020–2027：製品種類別（カプノグラフ（メインストリームカプノグラフ、サイドストリームカプノグラフ、マイクロストリームカプノグラフ）・カプノグラフィー使い捨て品）、用途別、エンドユーザー別
    AMR20PL032 / Allied Market Research / 2020年6月 / 本調査レポートでは、カプノグラフィーの世界市場について調査・分析することにより、イントロダクション、エグゼクティブサマリー、市場概要、製品種類別（カプノグラフ、カプノグラフィー使い捨て品）分析、用途別分析、エンドユーザー別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・カプノグラフィーの世界市場規模：製品種類別（カプノグラフ、カプノグラフィー使い捨て品） ・カプノグラフィーの世界市場規模：用途別 ・カプノグラフィーの世界市場規模：エンドユーザー別 ・カプノグラフィーの世界市場規模：地域別 ・企業情報 ...The global capnography market accounted for $393.93 million in 2019, and is expected to reach $1,181.55 million by 2027, registering a CAGR of 13.5% from 2020 to 2027. Capnography is a medical tool that measures concentration or partial pressure of excised or current carbon dioxide. During anesthesia and intensive care, it is mostly used to monitor CO2 in respiratory gases. It also helps to diagnose causes of respiratory distress, provide feedback on treatment effects in real time, and detect shocks. Growth in prevalence of respiratory diseases, rise in surgeries, and increase in geriatric population boosts the market growth. In addition,...
  5. 血液バンクの世界市場2020–2027：製品種類別（全血、赤血球、血小板、血漿、白血球）、機能別、バンクタイプ別、エンドユーザー別
    AMR20JL055 / Allied Market Research / 2020年5月 / 本調査レポートでは、血液バンクの世界市場を広く調査・分析し、イントロダクション、エグゼクティブサマリー、市場動向、製品種類別（全血、赤血球、血小板、血漿、白血球）分析、機能別分析、バンクタイプ別分析、エンドユーザー別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・イントロダクション ・エグゼクティブサマリー ・市場動向 ・血液バンクの世界市場規模：製品種類別（全血、赤血球、血小板、血漿、白血球） ・血液バンクの世界市場規模：機能別 ・血液バンクの世界市場規模：バンクタイプ別 ・血液バンクの世界市場規模：エンドユーザー別 ・血液バンクの世界市場規模：地域別 ・企業情報...The global blood bank market was valued at $13.85 billion in 2019 and is expected to reach $21.86 billion by 2027, registering a CAGR of 5.7% from 2020 to 2027. A blood bank is a non-profit organization that engages in all the operations such as collection, processing, testing, storage, and distribution of blood and blood components drawn from donors. A blood bank can be a separate free-standing organization or operates as a part of a hospital. In addition, a blood bank provides safe or disease-free blood for transfusion to save a patient's life and curb the complications that can arise...
  6. 好中球減少症治療の世界市場2020–2027：治療別（コロニー刺激因子、抗生物質、抗真菌薬、抗ウイルス薬）、流通経路別
    AMR20JL063 / Allied Market Research / 2020年5月 / 本調査レポートでは、好中球減少症治療の世界市場を広く調査・分析し、イントロダクション、エグゼクティブサマリー、市場動向、治療別（コロニー刺激因子、抗生物質、抗真菌薬、抗ウイルス薬）分析、流通経路別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・イントロダクション ・エグゼクティブサマリー ・市場動向 ・好中球減少症治療の世界市場規模：治療別（コロニー刺激因子、抗生物質、抗真菌薬、抗ウイルス薬） ・好中球減少症治療の世界市場規模：流通経路別 ・好中球減少症治療の世界市場規模：地域別 ・企業情報...The global neutropenia treatment market was valued at $12,602.5 million in 2019, and is expected to reach $19,303.1 million by 2027, with a CAGR of 5.4% during the forecast period. Neutropenia refers to reduced neutrophil count in the blood. Normal individuals have a neutrophil count in the blood ranging between 1,500 and 8,000 cells/cubic meter. When neutrophil count falls below the 1,500 cells/mm3 threshold, a patient is classified as neutropenic. Generally, neutrophils drop below normal level within after 7-12 days of cancer chemotherapy. The demand for neutropenia therapy is projected to experience substantial growth in the future, owing to growth...
  7. 血液の世界市場2020–2027：製品別（全血収集・処理、ソースプラズマコレクション、血液型判定製品、血液スクリーニング製品）、エンドユーザー別
    AMR20JL062 / Allied Market Research / 2020年5月 / 本調査レポートでは、血液の世界市場を広く調査・分析し、イントロダクション、エグゼクティブサマリー、市場動向、製品別（全血収集・処理、ソースプラズマコレクション、血液型判定製品、血液スクリーニング製品）分析、エンドユーザー別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・イントロダクション ・エグゼクティブサマリー ・市場動向 ・血液の世界市場規模：製品別（全血収集・処理、ソースプラズマコレクション、血液型判定製品、血液スクリーニング製品） ・血液の世界市場規模：エンドユーザー別 ・血液の世界市場規模：地域別 ・企業情報...The blood market accounted for $7,201 million in 2020, and is expected to reach $10,253 million by 2027, registering a CAGR of 4.5% from 2020 to 2027. Blood is vital for life and is required for normal functioning of the human body. Furthermore, bone marrow is responsible for the production of blood cells in the body. However, various medical conditions can lead to altered level of blood, which can be fatal for a patient. For instance, medical conditions such as chronic kidney diseases, cancer, and hemophilia B require blood transfusions for treatment. Moreover, in event of a trauma, which causes...
  8. バタフライニードルセットの世界市場2020–2027：用途別（輸血、静脈穿刺、静脈内水分補給、薬剤投与）、エンドユーザー別
    AMR20PL058 / Allied Market Research / 2020年6月 / 本調査レポートでは、バタフライニードルセットの世界市場について調査・分析することにより、イントロダクション、エグゼクティブサマリー、市場概要、用途別（輸血、静脈穿刺、静脈内水分補給、薬剤投与）分析、エンドユーザー別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・バタフライニードルセットの世界市場規模：用途別（輸血、静脈穿刺、静脈内水分補給、薬剤投与） ・バタフライニードルセットの世界市場規模：エンドユーザー別 ・バタフライニードルセットの世界市場規模：地域別 ・企業情報 ...The global butterfly needle blood collection set market was $166.60 million in 2019, and is expected to reach $320.02 million by 2027, registering a CAGR 8.20% from 2020 to 2027. A butterfly needle is a device used to provide access to superficial vein for drawing blood or for an IV injection. These needles are much easier to use and is less painful due to winged tubing structure that allows greater flexibility. In addition, butterfly needles, also known as a winged infusion set or a scalp vein set, are commonly used for babies, young children, and elderly to draw blood or...
  9. 陰圧創傷治療装置の世界市場2020–2027：製品別（従来型NPWT装置、使い捨てNPWT装置）、用途別、エンドユーザー別
    AMR20JL064 / Allied Market Research / 2020年5月 / 本調査レポートでは、陰圧創傷治療装置の世界市場を広く調査・分析し、イントロダクション、エグゼクティブサマリー、市場動向、製品別（従来型NPWT装置、使い捨てNPWT装置）分析、創傷種類別分析、エンドユーザー別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・イントロダクション ・エグゼクティブサマリー ・市場動向 ・陰圧創傷治療装置の世界市場規模：製品別（従来型NPWT装置、使い捨てNPWT装置） ・陰圧創傷治療装置の世界市場規模：創傷種類別 ・陰圧創傷治療装置の世界市場規模：エンドユーザー別 ・陰圧創傷治療装置の世界市場規模：地域別 ・企業情報...The negative pressure wound therapy (NPWT) devices accounted for $2,144 million in 2020, and is expected to reach $3,347 million by 2027, registering a CAGR of 5.7% from 2020 to 2027. Negative pressure wound therapy (NPWT) devices are one of the most commonly used therapies to treat acute and chronic wounds. These devices work by creating negative pressure around the wounds, which leads to the flowing out of exudate from the wound. In addition, NPWT devices promote wound healing, reduce recurrent use of dressings (as in case of traditional wound care), provide an efficient option for management of closed surgical...
  10. 医薬品開発及び創薬向け人工知能の世界市場2019–2027：種類別（ターゲット特定、分子スクリーニング、デノボドラッグデザイン・ドラッグ最適化、前臨床・臨床試験）、疾患別、エンドユーザー別
    AMR20PL048 / Allied Market Research / 2020年6月 / 本調査レポートでは、医薬品開発及び創薬向け人工知能の世界市場について調査・分析することにより、イントロダクション、エグゼクティブサマリー、市場概要、種類別（ターゲット特定、分子スクリーニング、デノボドラッグデザイン・ドラッグ最適化、前臨床・臨床試験）分析、疾患別分析、エンドユーザー別分析、地域別分析、企業情報など、今後の市場展望をまとめております。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・医薬品開発及び創薬向け人工知能の世界市場規模：種類別（ターゲット特定、分子スクリーニング、デノボドラッグデザイン・ドラッグ最適化、前臨床・臨床試験） ・医薬品開発及び創薬向け人工知能の世界市場規模：疾患別 ・医薬品開発及び創薬向け人工知能の世界市場規模：エンドユーザー別 ・医薬品開発及び創薬向け人工知能の世界市場規模：地域別 ・企業情報 ...The artificial intelligence for drug discovery and development market was valued at $520 million in 2019 and is projected to reach $4,815 million by 2027, registering a CAGR of 31.6% from 2020 to 2027. Artificial intelligence (AI) is science and engineering adopted to design intelligent machines, especially intelligent computer programs. AI is an intelligent system that relates various human intelligence based functions such as reasoning, learning, and problem-solving skills on different disciplines such as biology, computer science, psychology, mathematics, linguistics, and engineering. In the healthcare industry, AI is applicable in medication management, treatment plans, drug discovery& developments and others. Drug...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆